Skip to content

PHARMA-THIM: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARMA-THIM

BE 0829.419.482
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€75,938
2024 · €60,338+€15,600
Equity
€432,465
2024 · €356,527+€75,938
Cash
€27,587
2024 · €88,304-€60,717
Balance sheet total
€883,008
2024 · €779,874+€103,134

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€142,403

    up €142,403 (+50.7%), from €281,028 to €423,431

    of which Land and buildings: +€140,333

  • Cash -€60,717

    down €60,717 (-68.8%), from €88,304 to €27,587

    mainly Investment in fixed assets (net) (-€169,872) and Trade debts (-€80,883)

  • Receivables within one year +€55,637

    up €55,637 (+64.0%), from €86,962 to €142,600

    of which Trade receivables: +€39,614

  • Intangible fixed assets -€32,503

    down €32,503 (-17.4%), from €186,889 to €154,386

Equity and liabilities
  • Debts after one year +€127,773

    up €127,773 (+58.1%), from €219,774 to €347,546

  • Trade debts -€80,883

    down €80,883 (-84.3%), from €95,922 to €15,040

    of which Suppliers: -€62,502

  • Reserves +€75,938

    up €75,938 (+22.1%), from €344,127 to €420,065

    of which Distributable reserves: +€75,938

  • Current portion of long-term debt -€23,917

    down €23,917 (-29.3%), from €81,734 to €57,817

Income statement
  • Staff costs -€17,178

    down €17,178 (-27.7%), from €62,084 to €44,906

  • Other operating charges +€10,875

    up €10,875 (+350%), from €3,104 to €13,979

  • Gross operating margin +€7,459

    up €7,459 (+3.1%), from €241,682 to €249,141

  • Taxes -€2,561

    down €2,561 (-6.2%), from €41,203 to €38,642

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €60,338
Gross operating margin +€7,459
Staff costs +€17,178
Depreciation +€1,157
Other operating charges -€10,875
Financial income +€142
Financial charges -€2,021
Taxes +€2,561
Result 2025 €75,938
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€5,300
Investment -€169,872
Financing +€103,855
Cash 2024 €88,304
Net result for the year +€75,938
Depreciation +€59,972
Stocks and contracts +€1,515
Receivables within one year -€55,637
Deferred charges and accrued income +€172
Trade debts -€80,883
Tax, wage and social debts +€4,223
Investment in fixed assets (net) -€169,872
Debts after one year +€127,773
Current portion of long-term debt -€23,917
Cash 2025 €27,587
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €779,874 €883,008 +€103,134 +13.2%
Fixed assets 21/28 €469,541 €579,441 +€109,900 +23.4%
Intangible fixed assets 21 €186,889 €154,386 -€32,503 -17.4%
Tangible fixed assets 22/27 €281,028 €423,431 +€142,403 +50.7%
Land and buildings 22 €266,694 €407,027 +€140,333 +52.6%
Plant, machinery and equipment 23 €3,768 €16,404 +€12,636 +335%
Furniture and vehicles 24 €10,566 €0 -€10,566 -100%
Financial fixed assets 28 €1,624 €1,624 = 0.0%
Current assets 29/58 €310,333 €303,567 -€6,766 -2.2%
Stocks and contracts in progress 3 €134,825 €133,310 -€1,515 -1.1%
Stocks 30/36 €134,825 €133,310 -€1,515 -1.1%
Amounts receivable within one year 40/41 €86,962 €142,600 +€55,637 +64.0%
Trade receivables 40 €40,595 €80,209 +€39,614 +97.6%
Other amounts receivable 41 €46,368 €62,391 +€16,023 +34.6%
Cash at bank and in hand 54/58 €88,304 €27,587 -€60,717 -68.8%
Deferred charges and accrued income 490/1 €242 €70 -€172 -71.1%
Total equity and liabilities 10/49 €779,874 €883,008 +€103,134 +13.2%
Equity 10/15 €356,527 €432,465 +€75,938 +21.3%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €344,127 €420,065 +€75,938 +22.1%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 €342,267 €418,205 +€75,938 +22.2%
Amounts payable 17/49 €423,347 €450,543 +€27,196 +6.4%
Amounts payable after more than one year 17 €219,774 €347,546 +€127,773 +58.1%
Financial debts 170/4 €219,774 €347,546 +€127,773 +58.1%
Amounts payable within one year 42/48 €203,573 €102,997 -€100,577 -49.4%
Current portion of amounts payable after more than one year 42 €81,734 €57,817 -€23,917 -29.3%
Trade debts 44 €95,922 €15,040 -€80,883 -84.3%
Suppliers 440/4 €77,542 €15,040 -€62,502 -80.6%
Bills of exchange payable 441 €18,380 - -€18,380
Taxes, remuneration and social security 45 €25,917 €30,141 +€4,223 +16.3%
Taxes 450/3 €15,407 €20,964 +€5,556 +36.1%
Remuneration and social security 454/9 €10,510 €9,177 -€1,333 -12.7%
Remuneration, social security and pensions 62 €62,084 €44,906 -€17,178 -27.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €61,130 €59,972 -€1,157 -1.9%
Other operating charges 640/8 €3,104 €13,979 +€10,875 +350%
Gross operating margin 9900 €241,682 €249,141 +€7,459 +3.1%
Operating profit (loss) 9901 €115,365 €130,283 +€14,918 +12.9%
Financial income 75/76B - €142 +€142
Recurring financial income 75 - €142 +€142
Financial charges 65/66B €13,824 €15,845 +€2,021 +14.6%
Recurring financial charges 65 €13,824 €15,845 +€2,021 +14.6%
Profit (loss) for the period before taxes 9903 €101,541 €114,580 +€13,039 +12.8%
Income taxes 67/77 €41,203 €38,642 -€2,561 -6.2%
Profit (loss) for the period 9904 €60,338 €75,938 +€15,600 +25.9%
Profit (loss) for the period to be appropriated 9905 €60,338 €75,938 +€15,600 +25.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.